Why the investor craze for Ozempic and rival weight-loss drugs may resume next year

Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance of GLP agonists in 2025, Barclays analysts said

Topics

Elon Musk contradicts RFK Jr.'s sentiments on weight loss drugs

Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.
ABC News - 3d
What other conditions could weight-loss drugs treat?

Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’s
Financial Times - 4d
Investors may face a major inflation surprise next year. How pros are preparing.

Big investment managers like Nuveen are factoring in the possibility that their base-case expectations for a soft landing, accompanied by easing inflation, might turn out to be wrong.
MarketWatch - 6d
Some health experts warn against microdosing weight loss drugs

The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and unpleasant side effects for some people. The New York Times reports some ...
CBS News - 6d
The weight-loss drug boom has become one of the internet's biggest scams

As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.
CNBC - Dec. 8
Weight-loss drug Mounjaro 'changed my life,' says mother-of-two

People struggling with their weight welcome the NHS rollout of Mounjaro but worry about delays.
BBC News - Dec. 5
Millions will have to wait up to 12 years for NHS weight-loss drug

Fears that giving 3.4 million people immediate access to new weight-loss drug could overwhelm NHS.
BBC News - Dec. 5
Eli Lilly's obesity drug beats rival in head-to-head trial — where Cramer sees shares going next

New trial data has cemented Club holding Eli Lilly's pole position in the highly competitive weight loss drug race.
CNBC - Dec. 4
A rival weight loss drug to Wegovy helped people shed more pounds, study shows

People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical trial, Lilly said in a release Wednesday.
NBC News - Dec. 4

Why the investor craze for Ozempic and rival weight-loss drugs may resume next year

Topics

Related

Elon Musk contradicts RFK Jr.'s sentiments on weight loss drugs

What other conditions could weight-loss drugs treat?

Investors may face a major inflation surprise next year. How pros are preparing.

Some health experts warn against microdosing weight loss drugs

The weight-loss drug boom has become one of the internet's biggest scams

Weight-loss drug Mounjaro 'changed my life,' says mother-of-two

Millions will have to wait up to 12 years for NHS weight-loss drug

Eli Lilly's obesity drug beats rival in head-to-head trial — where Cramer sees shares going next

A rival weight loss drug to Wegovy helped people shed more pounds, study shows

More from MarketWatch

I want a retirement-income solution with a 100% chance of success

Treasury yields hold steady after mixed data on services sector, manufacturing

Roth conversions may suddenly seem like a bad idea, but here’s why retirees are still considering them

‘The odds of winning are far better than a trip to Vegas’: I’m 76, still working and playing the stock market. Am I gambling?

The Social Security Fairness Act is incredibly irresponsible